Emcure Pharmaceuticals Limited

EMCURE

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20261,668

    Quarter₹ croreYoY
    Sept 20241,105—
    Dec 20241,029—
    Mar 20251,278—
    Jun 20251,097+13.0%
    Sept 20251,261+14.1%
    Dec 20251,418+37.9%
    Mar 20261,468+14.8%
    Jun 20261,451+32.3%
    Sept 20261,668+32.3%
  • ₹ crore

    Sept 202634

    Quarter₹ crore
    Sept 202455
    Dec 202419
    Mar 202522
    Jun 202522
    Sept 202523
    Dec 2025138
    Mar 202627
    Jun 202625
    Sept 202634
  • ₹ crore

    Sept 20261,702

    Quarter₹ crore
    Sept 20241,160
    Dec 20241,048
    Mar 20251,301
    Jun 20251,118
    Sept 20251,283
    Dec 20251,557
    Mar 20261,495
    Jun 20261,476
    Sept 20261,702
  • Cost structure
  • ₹ crore

    Sept 2026231

    Quarter₹ crore
    Sept 2024191
    Dec 2024196
    Mar 2025198
    Jun 2025210
    Sept 2025203
    Dec 2025206
    Mar 2026202
    Jun 2026210
    Sept 2026231
  • ₹ crore

    Sept 20261,369

    Quarter₹ crore
    Sept 20241,040
    Dec 2024981
    Mar 20251,115
    Jun 2025949
    Sept 20251,125
    Dec 20251,213
    Mar 20261,196
    Jun 20261,207
    Sept 20261,369
  • Exceptional items and tax
  • ₹ crore

    Sept 2026332

    Quarter₹ crore
    Sept 2024119
    Dec 202467
    Mar 2025186
    Jun 2025166
    Sept 2025158
    Dec 2025314
    Mar 2026306
    Jun 2026269
    Sept 2026332
  • ₹ crore

    Sept 202684

    Quarter₹ crore
    Sept 202432
    Dec 202417
    Mar 202546
    Jun 202543
    Sept 202540
    Dec 202556
    Mar 202673
    Jun 202669
    Sept 202684
  • Profit
  • ₹ crore

    Sept 2026248

    Quarter₹ croreYoY
    Sept 202487—
    Dec 202450—
    Mar 2025140—
    Jun 2025123+203.6%
    Sept 2025118+35.3%
    Dec 2025259+415.6%
    Mar 2026234+67.5%
    Jun 2026200+63.0%
    Sept 2026248+111.2%
  • Per share
  • ₹ per share

    Sept 202613.10

    Quarter₹ per share
    Sept 20244.62
    Dec 20242.65
    Mar 20257.37
    Jun 20256.48
    Sept 20256.21
    Dec 202513.65
    Mar 202612.33
    Jun 202610.55
    Sept 202613.10
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
1,1051,0291,2781,0971,2611,4181,4681,4511,668
Revenue YoY———+13.0%+14.1%+37.9%+14.8%+32.3%+32.3%
5519222223138272534
1,1601,0481,3011,1181,2831,5571,4951,4761,702
Cost structure
191196198210203206202210231
1,0409811,1159491,1251,2131,1961,2071,369
Exceptional items and tax
11967186166158314306269332
321746434056736984
Profit
8750140123118259234200248
Net profit YoY———+203.6%+35.3%+415.6%+67.5%+63.0%+111.2%
Per share
4.622.657.376.486.2113.6512.3310.5513.10

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.